We are live on ! Find out more
PODD icon

Insulet

834 hedge funds and large institutions have $20B invested in Insulet in 2025 Q4 according to their latest regulatory filings, with 124 funds opening new positions, 327 increasing their positions, 268 reducing their positions, and 87 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more first-time investments, than exits

New positions opened: 124 | Existing positions closed: 87

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

22% more repeat investments, than reductions

Existing positions increased: 327 | Existing positions reduced: 268

2.99% more ownership

Funds ownership: 97.02%100.01% (+3%)

3% more funds holding

Funds holding: 813834 (+21)

5% less capital invested

Capital invested by funds: $21.1B → $20B (-$1.08B)

11% less call options, than puts

Call options by funds: $84.1M | Put options by funds: $94.8M

Holders
834
Holders Change
+21
Holders Change %
+2.58%
% of All Funds
10.09%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
124
Increased
327
Reduced
268
Closed
87
Calls
$84.1M
Puts
$94.8M
Net Calls
-$10.7M
Net Calls Change
+$81.5M

PODD Hedge Fund Activity: Q4 2025 in Review

834 of the 8,266 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q4 2025, worth a combined $20B — down 5.1% from $21.1B a quarter earlier.

Buyers outnumbered sellers: 124 funds opened new PODD positions and 87 closed out — a net gain of 37 holders — while 327 added to existing stakes and 268 trimmed.

The largest buyer was VOYA Investment Management, adding an estimated $105M. The largest seller was Fidelity Investments, cutting an estimated $389M.

  • 834 institutional investors held Insulet (PODD) as of Q4 2025, up from 813 in Q3 2025.
  • Funds reported $20B of Insulet stock for Q4 2025, down 5.1% quarter-over-quarter.
  • 124 funds opened new Insulet positions in Q4 2025 and 87 closed out, a net change of +37 holders.
  • The largest Insulet buyer in Q4 2025 was VOYA Investment Management, an estimated $105M added.
  • The largest Insulet seller in Q4 2025 was Fidelity Investments, an estimated $389M sold.

Based on aggregated 13F filings for Q4 2025.